Answers are grounded in this paper and cite their sources.
In Brief The purpose of this study was to explore the benefit of high-dose intravaginal metronidazole as a maintenance therapy in reducing recurrence rates of bacterial vaginosis (BV). Eighteen women with a history of recurrent BV and symptomatic BV were treated with metronidazole 750 mg suppository intravaginally daily for 7 days. Those in remission by Amsel criteria received metronidazole 750 mg twice weekly for 3 months with further follow-up for 3 months. High-dose metronidazole intravaginally was associated with rare clinical recurrence during the period of use. After cessation of suppression therapy, recurrence was high. For women with recurrent bacterial vaginosis, using long-term suppressive high-dose vaginal metronidazole may decrease the frequency of recurrent episodes of symptomatic BV.
No takes yet. Share an insight, caveat, or question.
Aguin et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: